These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 23760588

  • 1. D2 lymphadenectomy with surgical ex vivo dissection into node stations for gastric adenocarcinoma can be performed safely in Western patients and ensures optimal staging.
    Schmidt B, Chang KK, Maduekwe UN, Look-Hong N, Rattner DW, Lauwers GY, Mullen JT, Yang HK, Yoon SS.
    Ann Surg Oncol; 2013 Sep; 20(9):2991-9. PubMed ID: 23760588
    [Abstract] [Full Text] [Related]

  • 2. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G, Aurello P, D'Angelo F, Cicchini C, Sternberg CN.
    Hepatogastroenterology; 2000 Sep; 47(35):1470-4. PubMed ID: 11100379
    [Abstract] [Full Text] [Related]

  • 3. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM, Koo J, Miloro SM, Driscoll DL, Nava HR, Douglass HO.
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [Abstract] [Full Text] [Related]

  • 4. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma.
    Memon MA, Subramanya MS, Khan S, Hossain MB, Osland E, Memon B.
    Ann Surg; 2011 May; 253(5):900-11. PubMed ID: 21394009
    [Abstract] [Full Text] [Related]

  • 5. D2 lymph node dissection improves staging in patients with gastric adenocarcinoma.
    Putchakayala K, Difronzo LA.
    Am Surg; 2011 Oct; 77(10):1326-9. PubMed ID: 22127080
    [Abstract] [Full Text] [Related]

  • 6. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.
    Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P.
    Br J Cancer; 1999 Mar; 79(9-10):1522-30. PubMed ID: 10188901
    [Abstract] [Full Text] [Related]

  • 7. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
    Ikeguchi M, Oka S, Gomyo Y, Tsujitani S, Maeta M, Kaibara N.
    Anticancer Res; 2000 Mar; 20(2B):1285-9. PubMed ID: 10810436
    [Abstract] [Full Text] [Related]

  • 8. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
    Roukos DH, Lorenz M, Encke A.
    Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
    [Abstract] [Full Text] [Related]

  • 9. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
    Di Martino N, Izzo G, Cosenza A, Vicenzo L, Monaco L, Torelli F, Basciotti A, Brillantino A, Marra A.
    Suppl Tumori; 2005 May; 4(3):S84-5. PubMed ID: 16437920
    [Abstract] [Full Text] [Related]

  • 10. Aggressive D2 lymphadenectomy is required for accurate pathologic staging of gastric adenocarcinoma.
    Smith BR, Stabile BE.
    Am Surg; 2006 Oct; 72(10):849-52. PubMed ID: 17058719
    [Abstract] [Full Text] [Related]

  • 11. What is the role of nodal ratio as a prognostic factor for gastric cancer nowadays? Comparison with new TNM staging system and analysis according to the number of resected nodes.
    Aurello P, Catracchia V, Petrucciani N, D'Angelo F, Leonardo G, Picchetto A, Antolino L, Magistri P, Terrenato I, Lauro A, Ramacciato G.
    Am Surg; 2013 May; 79(5):483-91. PubMed ID: 23635583
    [Abstract] [Full Text] [Related]

  • 12. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.
    Volpe CM, Driscoll DL, Douglass HO.
    Ann Surg Oncol; 2000 Mar; 7(2):139-44. PubMed ID: 10761793
    [Abstract] [Full Text] [Related]

  • 13. [The prognostic influence of D2 lymphadenectomy with para-aortic lymph nodal dissection for gastric cancer in N3 stage].
    Liang YX, Liang H, Ding XW, Wang XN, Zhang L, Wu LL, Liu HG, Jiao XG.
    Zhonghua Wai Ke Za Zhi; 2013 Dec; 51(12):1071-6. PubMed ID: 24499714
    [Abstract] [Full Text] [Related]

  • 14. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative.
    Randle RW, Swords DS, Levine EA, Fino NF, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Pawlik TM, Jin LX, Spolverato G, Schmidt C, Worhunsky D, Cho CS, Maithel SK, Votanopoulos KI.
    J Surg Oncol; 2016 Jun; 113(7):750-5. PubMed ID: 26996496
    [Abstract] [Full Text] [Related]

  • 15. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide, Lin D, Li Y, Xu H, Chen J, Wang B, Liu C, Lu P.
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [Abstract] [Full Text] [Related]

  • 16. [The role of superextended lymphadenectomy (D4) in gastric cancer].
    Pugliese R, Maggioni D, Sansonna F, Scandroglio I, Di Lernia S, Boniardi M, Bramerio MA.
    Minerva Chir; 2004 Aug; 59(4):325-35. PubMed ID: 15278027
    [Abstract] [Full Text] [Related]

  • 17. A prospective observational study of 468 patients undergoing D2 or D3 lymphadenectomy for gastric cancer.
    Bostanci EB, Ozer I, Ercan M, Ulas M, Koc U, Karaman K, Dalgic T, Ozogul Y, Akoglu M.
    Hepatogastroenterology; 2013 May; 60(123):624-7. PubMed ID: 23635437
    [Abstract] [Full Text] [Related]

  • 18. Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis.
    Shridhar R, Dombi GW, Weber J, Hoffe SE, Meredith K, Konski A.
    Am J Clin Oncol; 2012 Jun; 35(3):216-21. PubMed ID: 21378540
    [Abstract] [Full Text] [Related]

  • 19. Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer?
    Biondi A, D'Ugo D, Cananzi FC, Papa V, Borasi A, Sicoli F, Degiuli M, Doglietto G, Persiani R.
    Eur J Surg Oncol; 2015 Jun; 41(6):779-86. PubMed ID: 25899981
    [Abstract] [Full Text] [Related]

  • 20. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
    Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ.
    Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.